1. Home
  2. BMRN vs THC Comparison

BMRN vs THC Comparison

Compare BMRN & THC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BMRN
  • THC
  • Stock Information
  • Founded
  • BMRN 1996
  • THC 1967
  • Country
  • BMRN United States
  • THC United States
  • Employees
  • BMRN N/A
  • THC N/A
  • Industry
  • BMRN Biotechnology: Pharmaceutical Preparations
  • THC Hospital/Nursing Management
  • Sector
  • BMRN Health Care
  • THC Health Care
  • Exchange
  • BMRN Nasdaq
  • THC Nasdaq
  • Market Cap
  • BMRN 12.1B
  • THC 11.7B
  • IPO Year
  • BMRN 1999
  • THC N/A
  • Fundamental
  • Price
  • BMRN $58.07
  • THC $168.68
  • Analyst Decision
  • BMRN Buy
  • THC Buy
  • Analyst Count
  • BMRN 22
  • THC 17
  • Target Price
  • BMRN $93.43
  • THC $177.24
  • AVG Volume (30 Days)
  • BMRN 2.2M
  • THC 1.4M
  • Earning Date
  • BMRN 05-01-2025
  • THC 07-23-2025
  • Dividend Yield
  • BMRN N/A
  • THC N/A
  • EPS Growth
  • BMRN 152.82
  • THC N/A
  • EPS
  • BMRN 2.71
  • THC 15.09
  • Revenue
  • BMRN $2,950,227,000.00
  • THC $20,520,000,000.00
  • Revenue This Year
  • BMRN $12.27
  • THC $2.17
  • Revenue Next Year
  • BMRN $10.08
  • THC $4.98
  • P/E Ratio
  • BMRN $21.47
  • THC $11.18
  • Revenue Growth
  • BMRN 19.36
  • THC N/A
  • 52 Week Low
  • BMRN $52.93
  • THC $109.82
  • 52 Week High
  • BMRN $94.85
  • THC $171.20
  • Technical
  • Relative Strength Index (RSI)
  • BMRN 41.32
  • THC 70.90
  • Support Level
  • BMRN $57.27
  • THC $163.62
  • Resistance Level
  • BMRN $59.12
  • THC $170.42
  • Average True Range (ATR)
  • BMRN 1.40
  • THC 4.98
  • MACD
  • BMRN 0.06
  • THC -0.28
  • Stochastic Oscillator
  • BMRN 18.34
  • THC 90.88

About BMRN BioMarin Pharmaceutical Inc.

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.

About THC Tenet Healthcare Corporation

Tenet Healthcare is a Dallas-based healthcare services organization. It operates a collection of hospitals (about 60 as of December 2023) and over 450 ambulatory surgery centers and other outpatient facilities across the U.S., primarily in the South. Through its Conifer segment, Tenet also provides revenue cycle management solutions.

Share on Social Networks: